Replies to post #52910 on Biotech Values

[AlpineBV_Miller]

One down and one to go of the two that shorted their own stock.

I still find it funny that Vanda inlicensed iloperidone from Novartis and not Titan, yet Titan still lists it as a drug they are developing.